Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00379301 · ClinicalTrials.gov registry record · NA
Efficacy of Different Ablation Strategies for Controlling Atrial Fibrillation
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 166
- Enrollment target
NCT00379301: Completed NA study, sponsored by University of Pennsylvania.
NCT00379301 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 166 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00379301, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
Study Summary
This study involves treatment for atrial fibrillation (AF)-the most common heart condition in the US-where the upper chambers of the heart beat very fast and in a disorganized manner. This can be felt as palpitations, tiredness, shortness of breath and passing out, plus can lead to stroke, damage to the heart muscle and a shorter life span. Study participants will receive a common treatment for atrial fibrillation called radiofrequency ablation (RFA), where small lesions or "burns" are made inside the heart to cut off the abnormal impulses that cause AF. The purpose of this study is to compare the effectiveness of three different common ablation strategies in patients with persistent or permanent AF. Subjects will be randomized (like drawing straws) to be treated with one of the three strategies to see if there is a difference in how well atrial fibrillation is controlled after treatment.
Interventions
- PROCEDURE Radiofrequency ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2006-10 |
| Est. Completion | 2011-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00379301
The ClinicalTrials.gov registry entry for NCT00379301 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiofrequency ablation is the first listed.
NCT00379301 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00379301 about?
NCT00379301 is a clinical study titled "Efficacy of Different Ablation Strategies for Controlling Atrial Fibrillation". This study involves treatment for atrial fibrillation (AF)-the most common heart condition in the US-where the upper chambers of the heart beat very fast and in a disorganized manner. This can be felt as palpitations, tiredness, shortness of breath and passing out, plus can lead to stroke, damage to...
What is the current status of trial NCT00379301?
This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2006-10. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00379301?
The interventions under investigation include: Radiofrequency ablation (PROCEDURE).
Who is sponsoring clinical trial NCT00379301?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.